Celldex Therapeutics
CLDX
CLDX
141 hedge funds and large institutions have $348M invested in Celldex Therapeutics in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 51 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Holders
141
Holding in Top 10
–
Calls
$3.23M
Puts
$3.12M
Top Buyers
| 1 | +$10M | |
| 2 | +$8.44M | |
| 3 | +$7.25M | |
| 4 |
PP
PDT Partners
New York
|
+$2.17M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.16M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$12.1M | |
| 3 | -$10.3M | |
| 4 |
Millennium Management
New York
|
-$10.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.46M |